 |
||||
Prostate cancer hits one in nine men living in the U.S., and is the second leading cause of cancer death among American men. Yet when caught early, survival from prostate cancer is nearly 100 percent. Come hear urologist Dr. Carolyn Fronczak discuss the latest approaches for detecting prostate cancer, including new genomic urine and blood tests and multi-parametric MRI imaging. Then get an overview of the different risk categories for prostate cancer and how those categories influence follow-up and treatment options such as minimally invasive robotic-assisted surgery. SpeakerDr. Carolyn Fronczak, Urologist DateThursday, July 26, from 11 a.m. until noon Location |
Register now for this lecturePlease supply the following information:
Fill out my online form.
|
|||
|
|
|
|
|
 |
||||
|
  |
|||
Boulder Community Health (BCH) does not exclude, deny benefits to, or otherwise discriminate against any person on the grounds of race, color, or national origin, or on the basis of disability or age in admission to, participation in, or receipt of the services and benefits under any of its programs and activities, whether carried out by BCH directly or through a contract or any other entity with which BCH arranges to carry out its programs and activities.